Clonal patterns of X-chromosome inactivation in female patients with aplastic anaemia studied using a novel reverse transcription polymerase chain reaction method

European Journal of Haematology

Volumn 64, Issue 6, 2000, Pages 385-395

  Mortazavi, Y ^a   Chopra, R ^a   Gordon Smith, E C ^a   Rutherford, T R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

ASO hybridisation; Cell ageing; Clonality; DNA methylation; Extreme lyonisation

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE;

APLASTIC ANEMIA; ARTICLE; CHROMOSOME INACTIVATION; DNA METHYLATION; DNA POLYMORPHISM; FEMALE; GRANULOCYTE; HEMATOPOIESIS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESTRICTION SITE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; X CHROMOSOME;

ALLELES; ANEMIA, APLASTIC; CLONE CELLS; DOSAGE COMPENSATION, GENETIC; FEMALE; GENE EXPRESSION; GENOTYPE; GLUCOSEPHOSPHATE DEHYDROGENASE; HEMATOPOIESIS; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; IDURONATE SULFATASE; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0033917082     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2000.90150.x     Document Type: Article

References (55)

1. 1. GORDON-SMITH EC. Aplastic anaemia - aetiology and clinical features. Baillieres Clin Haematol 1989;2:1-18.
2. 2. NARAYANAN MN, GEARY CG, FREEMONT AJ, KENDRA JR. Long-term follow-up of aplastic anaemia. Br J Haematol 1994;86:837-843.
3. 3. SOCIE G, HENRY-AMAR M, BACIGALUPO A, et al. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med 1993;329:1152-1157.
4. 4. DE PLANQUE MM, BRAND A, KLUIN-NELEMANS HC, et al. Haematopoietic and immunologic abnormalities in severe aplastic anaemia patients treated with anti-thymocyte globulin. Br J Haematol 1989;71:421-430.
5. 5. TICHELLI A, GRATWOHL A, NISSEN C, SPECK B. Late clonal complications in severe aplastic anemia. Leuk Lymph 1994; 12:167-175.
6. 6. TICHELLI A, GRATWOHL A, WURSCH A, NISSEN C, SPECK B. Late haematological complications in severe aplastic anaemia. Br J Haematol 1988;69:413-418.
7. 7. SPECK B, GRATWOHL A, NISSEN C, et al. Treatment of severe aplastic anemia. Exp Hematol 1986;14:126-132.
8. 8. YOUNG NS. The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated. Blood 1992;79:1385-1392.
9. 9. VAN KAMP H, LANDEGENT JE, JANSEN RP, WILLEMZL R, FIBBE WE. Clonal hematopoiesis in patients with acquired aplastic anemia. Blood 1991;78:3209-3214.
10. 10. OHASHI H. Clonality in refractory anemia. Rinsho Ketsueki (Jpn J Clin Hematol) 1993;34:265-268.
11. 11. JOSTEN KM, TOOZE JA, BORTHWICK-CLARKE C, GORDON-SMITH EC, RUTHERFORD TR. Acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria: studies on clonality. Blood 1991;78:3162-3167.
12. 12. TSUGE I, KOJIMA S, MATSUOKA H, et al. Clonal haematopoiesis in children with acquired aplastic anaemia. Br J Haematol 1993;84:137-143.
13. 13. JINNAI I. Clonal study of hematopoietic cells. Rinsho Ketsueki (Jpn J Clin Hematol) 1995;36:273-278.
14. 14. RAGHAVACHAR A, JANSSEN JW, SCHREZENMEIER H, et al. Clonal hematopoiesis as defined by polymorphic X-linked loci occurs infrequently in aplastic anemia. Blood 1995; 86:2938-2947.
15. 15. NYCE J. Drug-induced DNA hypermethylation and drug resistance in human tumors. Cancer Res 1989;49:5829-5836.
16. 16. CACHIA PG, CULLIGAN DJ, THOMAS ED, WHITTAKER J, JACOBS A, PADUA RA. Methylation of the DXS255 hypervariable locus 5′ CCGG site may be affected by factors other than X-chromosome activation status. Genomics 1992;14:70-74.
17. 17. HODGES E, HOWELL WM, BOYD Y, SMITH JL. Variable X-chromosome DNA methylation patterns detected with probe M27 beta in a series of lymphoid and myeloid malignancies. Br J Haematol 1991;77:315-322.
18. 18. GALE RE, WHEADON H, LINCH DC. X-chromosome inactivation patterns using HPRT and PGK polymorphisms in haematologically normal and post-chemotherapy females. Br J Haematol 1991;79:193-197.
19. 19. PRCHAL JT, GUAN YL, PRCHAL JF, BARANY F. Transcriptional analysis of the active X-chromosome in normal and clonal hematopoiesis. Blood 1993;81:269-271.
20. 20. PRCHAL JT, GUAN YL. A novel clonality assay based on transcriptional analysis of the active X chromosome. Stem Cells 1993;11 Suppl 1:62-65.
21. 21. KURDI-HAIDAR B, MASON PJ, BERREBI A, ANKRA-BADU G, AL-ALI A, OPPENHEIM A, LUZZATTO L. Origin and spread of the glucose-6-phosphate dehydrogenase variant (G6PD-Mediterranean) in the Middle East. Am J Hum Genet 1990;47:1013-1019.
22. 22. BEUTLER E, KUHL W. The NT 1311 polymorphism of G6PD: G6PD Mediterranean mutation may have originated independently in Europe and Asia. Am J Hum Genet 1990;47: 1008-1012.
23. 23. LUHOVY M, LIU Y, BELICKOVA M, PRCHAL JF, PRCHAL JT. A novel clonality assay based on transcriptional polymorphism of X chromosome gene p55. Biol Blood Marrow Transplant 1995;1:81-87.
24. 24. JOSTEN KM, GORDON-SMITH EC, HEIMPEL H, RUTHERFORD TR. Detection of clonality in haemopoietic cells by reverse transcriptase-polymerase chain reaction. Exp Hematol 1993;21:1159-1159.
25. 25. LIU Y, PHELAN J, GO RCP, PRCHAL JF, PRCHAL JT. Rapid determination of clonality by detection of two closely-linked X chromosome exonic polymorphisms using allele-specific PCR. J Clin Invest 1997;99:1984-1990.
26. 26. EL-KASSAR N, HETET G, BRIERE J, GRANDCHAMP B. Clonality analysis of hematopoiesis in essential thrombocythemia: advantages of studying T lymphocytes and platelets. Blood 1997;89:128-134.
27. 27. JIN JY, TOOZE JA, MARSH JC, MATTHEY F, GORDON-SMITH EC. Myelodysplasia following aplastic anaemia-paroxysmal nocturnal haemoglobinuria syndrome after treatment with immunosuppression and G-CSF: evidence for the emergence of a separate clone. Br J Haematol 1996;94: 510-512.
28. 28. GLISIN V, CRKVENJAKOV R, BYUS C. Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry 1974;13: 2633-2637.
29. 29. BUNGE S, STEGLICH C, ZUTHER C, et al. Iduronate-2-sulfatase gene mutations in 16 patients with mucopolysaccharidosis type II (Hunter syndrome). Human Mol Genet 1993;2: 1871-1875.
30. 30. WHITE JR, JOSTEN KM, CHOPRA R, et al. Absence of N-RAS point mutations in peripheral blood cells of patients with aplastic anaemia and paroxysmal nocturnal haemoglobinurea. Br J Haematol 1995;91:921-923.
31. 31. VERLAAN-DE VRIES M, BOGAARD ME, VAN DEN ELST H, VAN BOOM JH, VAN DER EB AJ, BOS JL. A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides. Gene 1986;50:313-320.
32. 32. FIALKOW PJ. Use of genetic markers to study cellular origin and development of tumors in human females. [Review] [97 refs]. Adv Cancer Res 1972;15:191-226.
33. 33. VOGELSTEIN B, FEARON ER, HAMILTON SR, et al. Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res 1987;47:4806-4813.
34. 34. GALE RE, WHEADON H, LINCH DC. Assessment of X-chromosome inactivation patterns using the hypervariable probe M27 beta in normal hemopoietic cells and acute myeloid leukemic blasts. Leukemia 1992;6:649-655.
35. 35. PRCHAL JT, PRCHAL JF, BELICKOVA M, et al. Clonal stability of blood lineages indicated by X-chromosomal transcriptional polymorphism. J Exp Med 1996;183:561-567.
36. 36. MORTAZAVI Y, CHOPRA R, GORDON-SMITH EC, RUTHERFORD TR. Frequency of the G6PD nt 1311 C/T polymorphism in English and Iranian populations: relevance to studies of X chromosome inactivation. J Med Genet 1997;34:1028-1029.
37. 37. LUCAS GS, PADUA RA, MASTERS GS, OSCIER DG, JACOBS A. The application of X-chromosome gene probes to the diagnosis of myeloproliferative disease. Br J Haematol 1989;72:530-533.
38. 38. JANSSEN JW, BUSCHLE M, LAYTON M, et al. Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. Blood 1989;73:248-254.
39. 39. TEFFERI A, THIBODEAU SN, SOLBERG LA, JR. Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms. Blood 1990;75:1770-1773.
40. 40. ANGER B, JANSSEN JW, SCHREZENMEIER H, HEHLMANN R, HEIMPEL H, BARTRAM CR. Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms. Leukemia 1990;4:258-261.
41. 41. TSUKAMOTO N, MORITA K, MAEHARA T, et al. Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X-linked restriction fragment length polymorphisms. Br J Haematol 1993;83:589-594.
42. 42. EL KASSAR N, HETET G, LI Y, BRIERE J, GRANDCHAMP B. Clonal analysis of haemopoietic cells in essential thrombocythaemia. Br J Haematol 1995;90:131-137.
43. 43. GALE RE, LINCH DC. Investigation of methylation at Hha I sites using the hypervariable probe M27 beta allows improved clonal analysis in myeloid leukaemia and demonstrates differences in methylation between leukaemic and remission samples. Leukemia 1994;8:190-194.
44. 44. YAN L, ELKASSAR N, GARDIN C, BRIERE J. Clonality assays and megakaryocyte culture techniques in essential thrombocythemia. Leuk Lymph 1996;22 Suppl 1:31-40.
45. 45. GALE RE, WHEADON H, BOULOS P, LINCH DC. Tissue specificity of X-chromosome inactivation patterns. Blood 1994;83:2899-2905.
46. 46. BUSQUE L, MIO R, MATTIOLI J, et al. Nonrandom X-inactivation patterns in normal females: Iyonization ratios vary with age. Blood 1996;88:59-65.
47. 47. GALE RE, FIELDING AK, HRRISON CN, LINCH DC. Acquired skewing of X-chromosome inactivation patterns in myeloid cells of the elderly suggest stochostic clonal loss with age. Br J Haematol 1997;98:512-519.
48. 48. DE PLANQUE MM, KLUIN-NELEMANS HC, VAN KRIEKEN HJ, et al. Evolution of acquired severe aplastic anaemia to myelo-dysplasia and subsequent leukaemia in adults. Br J Haematol 1988;70:55-62.
49. 49. CHAMPION KM, GILBERT JG, ASIMAKOPOULOS FA, HINSHELWOOD S, GREEN AR. Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes. Br J Haematol 1997;97:920-926.
50. 50. BESSLER M, HILLMEN P, LUZZATTO L. Clonal origin of abnormal granulocytes in paroxysmal nocturnal hemoglobinuria. Blood 1992;80:844-845.
51. 51. GREGG XT, STOPKA T, WARE RE, COOPER MD, PRCHAL JT. Analysis of BFU-E colony formation and CD59 expression in PNH. Blood 1996;90:8a.
52. 52. BESSLER M, MASON P, HILLMEN P, LUZZATTO L. Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria. Lancet 1994;343:951-953.
53. 53. NAFA K, MASON PJ, HILLMEN P, LUZZATTO L, BESSLER M. Mutations in the PIG-A gene causing paroxysmal nocturnal hemoglobinuria are mainly of the frameshift type. Blood 1995;86:4650-4655.
54. 54. YAMADA N, MIYATA T, MAEDA K, KITANI T, TAKEDA J, KINOSHITA T. Somatic mutations of the PIG-A gene found in Japanese patients with paroxysmal nocturnal hemoglobinuria. Blood 1995;85:885-892.
55. 55. ENDO M, WARE RE, VREEKE TM, et al. Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria. Blood 1996;87:2546-2557.